MEDI-FIRST Topical Analgesic

LIDOCAINE HCI TOPICAL HUMAN OTC DRUG

MEDI-FIRST Topical Analgesic is an FDA drug label for the active ingredient LIDOCAINE HCI manufactured by Ultra Distributors Inc administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20260907.

Generic name
LIDOCAINE HCI
Manufacturer
Ultra Distributors Inc
Product type
HUMAN OTC DRUG
Route
TOPICAL
Dosage form
N/A
NDC
78495-142
Application
M017
Label effective
20260907

About this product

MEDI-FIRST Topical Analgesic is an FDA-registered drug product whose active ingredient is LIDOCAINE HCI. It is labelled by Ultra Distributors Inc taken by topical and marketed as a human otc drug product. Identifiers on file: NDC 78495-142, application M017, label effective 20260907. It is one of 3 FDA drug label records sharing the active ingredient LIDOCAINE HCI. This page reproduces the FDA-approved label text so you can check what a product is, who makes it and how it is supplied before discussing it with a pharmacist or prescriber.

What it is used for

Across FDA labelling, products containing LIDOCAINE HCI are most often described in connection with: temporary pain, relief associated, minor burns. Wording differs between labels, and the full indications section on this page takes precedence when it is present.

Active ingredients

Active ingredient Lidocaine HCI 2.0%

Indications & Usage

Uses Temporary pain relief associated with minor burns

Dosage & Administration

Directions spray an even layer of burn spray over cleaned affected area not more than 3-4 times daily not to be used on Children under 12 years of age

Warnings

Warnings For external use only.

More products with the same ingredient

LIDOCAINE HCI

Burn Gel

Trifecta Pharmaceuticals USA LLC View label

LIDOCAINE HCI

HF Acquisition Co LLC, DBA HealthFirst View label

How products containing LIDOCAINE HCI compare

FDA lists 3 drug label records with LIDOCAINE HCI as the active ingredient. The most common dosage forms and the manufacturers with the most records are summarised below; strengths, pack sizes and inactive ingredients can still differ between apparently similar products.

Dosage formProductsManufacturerProducts
— — HF Acquisition Co LLC, DBA HealthFirst 1
— — Trifecta Pharmaceuticals USA LLC 1
— — Ultra Distributors Inc 1
— — — —
— — — —

Frequently asked questions

What is MEDI-FIRST Topical Analgesic used for?
Uses Temporary pain relief associated with minor burns

Who makes MEDI-FIRST Topical Analgesic?
Ultra Distributors Inc is the labeler of record for MEDI-FIRST Topical Analgesic. 3 FDA label records share the active ingredient LIDOCAINE HCI, so generic and branded versions may come from different companies; the manufacturer named on your pack is the one that matters for any enquiry.

What form does MEDI-FIRST Topical Analgesic come in?
administered by topical. Strengths and pack sizes vary by label, so compare the NDC on your pack with the identifier listed on this page.

Is MEDI-FIRST Topical Analgesic prescription or over-the-counter?
The FDA label for this product is recorded as human otc drug. Marketing status can differ between strengths and countries, so check the dispensing rules where you live.

Are there other products containing LIDOCAINE HCI?
Yes. 3 FDA drug label records list LIDOCAINE HCI as the active ingredient. Products with the same active ingredient can usually be substituted only when a prescriber or pharmacist confirms it is appropriate.

Has MEDI-FIRST Topical Analgesic been recalled?
No FDA recall record in our database matches this product name or manufacturer. Recall data is updated periodically, so a very recent notice may not appear here yet.

Where does this information come from?
All content is reproduced from FDA Structured Product Labelling data via openFDA. It is provided for identification and reference only and is not medical advice.

This page reproduces FDA Structured Product Labelling data for identification and reference. It is not medical advice, does not diagnose or treat any condition, and does not sell or price any medicine.